Related Experiment Video
Updated: Jun 12, 2026

08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
16.4K
Efficient and Low Cytotoxicity Gene Carriers Based on Amine-Functionalized Polyvinylpyrrolidone
Anselmo Del Prado1,2, Ana Civantos1,3, Enrique Martínez-Campos1,3
1Instituto de Ciencia y Tecnología de Polímeros, CSIC, Juan de la Cierva 3, 28006 Madrid, Spain.
Polymers
|November 20, 2020
Summary
New polyvinylpyrrolidone (PVP) derivatives show promise as non-viral gene delivery vectors. Modified PVP with piperidine groups demonstrated superior gene transfection efficiency and biocompatibility compared to polyethyleneimine (PEI).
Area of Science:
- Biomaterials Science
- Gene Therapy
- Polymer Chemistry
Background:
- Non-viral vectors are crucial for safe gene therapy delivery.
- Polyvinylpyrrolidone (PVP) is a promising, non-toxic polymer candidate for gene delivery.
- Functionalization of PVP can enhance its gene-carrying capabilities.
Purpose of the Study:
- To synthesize and evaluate novel polyvinylpyrrolidone (PVP) derivatives as non-viral gene carriers.
- To compare the gene delivery efficiency and cytocompatibility of modified PVP with polyethyleneimine (PEI).
Main Methods:
- Synthesis of PVP decorated with pyrrolidine, piperidine, and piperazine groups.
- DNA complexation studies using agarose gel electrophoresis and dynamic light scattering.
- In vitro transfection assays with murine fibroblast (Swiss 3T3) using luciferase reporter gene.
- Cytocompatibility assessment using calcein assay.
Main Results:
- All synthesized PVP copolymers effectively condensed DNA into polyplexes (100-400 nm) at N/P ratios ≥ 4:1.
- Piperidine-modified PVP exhibited higher transfection efficiency than pyrrolidine and piperazine analogs, outperforming PEI.
- PVP-based polyplexes showed significantly higher cytocompatibility (75-95%) compared to PEI (55%).
Conclusions:
- Functionalized PVP, particularly with piperidine groups, represents a potent and safe non-viral gene delivery system.
- These novel PVP derivatives offer a promising alternative to existing non-viral vectors like PEI for gene therapy applications.

